Dr. Archana Krishnan of BioGenomics, Kalyani Gongi of Ancient Living, Dr. M.Ratna Sudha of Unique Biotech, Dr. Nusrat J M Sanghamitra of CyCa OncoSolutions,Dr. Devlina Cakravarty of Artemis Global Life Sciences & Shonaal Lulla of Lamar Natural Products are in the race for the prestigious Pharma Leaders Innovative Business Woman of the year 2018
Pharma Leaders Innovative Business Woman of the year 2018
1. Dr. Archana Krishnan,Founder & Director of BioGenomics Limited
2. Ms. Kalyani Gongi,Managing Director, Ancient Living
3. Dr. M.Ratna Sudha,Managing Director, Unique Biotech Limited
4. Dr. Nusrat J M Sanghamitra,Founder, CEO, CyCa OncoSolutions Pvt. Ltd
5. Dr. Devlina Chakravarty,Managing Director,Artemis Global Life Sciences Limited
6. Ms.Shonaal Lulla, Director, Lamar Natural Products Pvt. Ltd.
These Innovative Business Women are running major research labs, redefining medical procedures and getting healthcare to those who most need it. try level. But as the seniority level rises, the gender gap widens and there is an ever-dwindling pool of women as candidates for top positions. There is an almost dry leadership pipeline at the top. We do find women at the entry and mid-levels, but the rates drop in the mid-management levels.
In the biotech sector, it’s estimated that there are only seven to nine per cent women playing the role of chief executive. Interestingly, this gender imbalance is not unique to pharma or biotech companies as women hold a mere four per cent of CEO positions in the Fortune 500 companies survey.
Although women have struggled for centuries to be recognized for their talent and the contribution they can bring to the pharmaceutical industry, significant strides have been made within the last 100 years. As a result, we have seen an increase in the number of female leaders and those with positions of power emerging in some of the largest pharmaceutical companies in the world.
India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK.India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immune Deficiency Syndrome) are supplied by Indian pharmaceutical firms.The pharmaceutical sector was valued at US$ 33 billion in 2017. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in 2017-18. In 2018-19 these exports are expected to cross US$ 19 billion.
Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.
India’s biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics is expected grow at an average growth rate of around 30 per cent a year and reach US$ 100 billion by 2025.
Pharmaleaders Power Brand Awards are the most prestigious annual industry awards, recognized annually that acknowledge and honor individuals and organizations for their remarkable accomplishments. These set of awards are widely acclaimed in the industry circle as fitting tribute to those individuals and companies that have gone the extra mile to advance the excellence in healthcare through best practices, initiatives,dynamism,drive & towering leadership. Pharmaleaders Business Leadership Awards are the premier largest business and technology leadership awards program in the sub continent , covering the set of prestigious awards spanning from biotech to Healthcare to CEO awards. Pharma Leaders Power Brand Awards are conferred to those Companies & Individuals who exhibit rare display of innovation for Outstanding Academic & Professional Leadership to individuals & Companies. This top recognition symbolizes the best out of best from chosen few.
